Overview
PPARG-related familial partial lipodystrophy is a genetic disorder characterized by loss of adipose tissue in the limbs and accumulation in the trunk, viscera, and face, often accompanied by metabolic complications such as insulin resistance and diabetes 1.Diagnosis
Genetic testing identifying mutations in the PPARG gene is crucial for diagnosis 1.
Clinical features include regional fat distribution anomalies and metabolic disturbances.
Laboratory tests should include assessment of glucose metabolism and lipid profiles 1.Management
Lifestyle modifications including diet and exercise are foundational 1.
Metformin may be considered for managing insulin resistance 1.
Lipid-lowering agents such as statins might be necessary for managing hyperlipidemia 1.
Specific PPARγ agonists like thiazolidinediones could be explored for metabolic control, though evidence is limited in this context 1.Special Populations
No specific guidance provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities 12.Key Recommendations
Confirm diagnosis through genetic testing for PPARG mutations (Evidence: Expert opinion) 1.
Implement lifestyle interventions including dietary modifications and physical activity (Evidence: Expert opinion) 1.
Consider metformin for the management of insulin resistance (Evidence: Expert opinion) 1.References
1 Bartoň L, Bureš D, Kott T, Řehák D. Associations of polymorphisms in bovine DGAT1, FABP4, FASN, and PPARGC1A genes with intramuscular fat content and the fatty acid composition of muscle and subcutaneous fat in Fleckvieh bulls. Meat science 2016. link
2 Martin JC, Valeille K. Conjugated linoleic acids: all the same or to everyone its own function?. Reproduction, nutrition, development 2002. link